Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes

por Chilton, R., Tikkanen, I., Cannon, C. P., Crowe, S., Woerle, H. J., Broedl, U. C., Johansen, O. E.
Publicado 2015

Health economic analysis of ticagrelor in patients with acute coronary syndromes intended for non-invasive therapy

por Janzon, M, James, S, Cannon, C P, Storey, R F, Mellström, C, Nicolau, J C, Wallentin, L, Henriksson, M
Publicado 2015